Estados financieros detallados de Immunome, Inc. (IMNM): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $23.46, IMNM presenta beneficios negativos (P/E no significativo) y un ROE del -50.56%. La capitalización bursátil es de $2.2B.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | $14.0M | $9.0M | $6.9M |
| Coste de Ventas | $521000 | $615000 | $755000 | 0 | 0 | 0 | 0 | $3.0M |
| Beneficio Bruto | -$521000 | -$615000 | -$755000 | 0 | 0 | $14.0M | $9.0M | $4.0M |
| I+D | $6.9M | $8.8M | $6.7M | $14.1M | $23.3M | $23.1M | $129.5M | $174.3M |
| Generales y Administrativos | $866000 | $1.5M | $4.8M | $11.1M | $13.6M | $19.7M | $33.0M | $43.8M |
| Gastos Operativos | $7.7M | $10.3M | $11.5M | $25.2M | $36.9M | $123.5M | $314.8M | $218.1M |
| Beneficio Operativo | -$7.7M | -$10.3M | -$12.3M | -$25.2M | -$36.9M | -$109.5M | -$305.8M | -$214.1M |
| EBITDA | -$7.2M | -$9.7M | -$17.0M | -$23.9M | -$36.3M | -$28.0M | -$151.4M | -$209.4M |
| Gastos por Intereses | $141000 | $106000 | $38000 | $10000 | $5000 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$7.8M | -$10.4M | -$17.8M | -$24.7M | -$36.9M | -$106.8M | -$293.0M | -$212.4M |
| Impuestos | $39000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$7.8M | -$10.6M | -$17.8M | -$24.7M | -$36.9M | -$106.8M | -$293.0M | -$212.4M |
| BPA | $-7.18 | $-1.84 | $-1.69 | $-2.14 | $-3.09 | $-5.38 | $-5.00 | $-2.43 |
| BPA Diluido | $-7.18 | $-1.84 | $-1.69 | $-2.14 | $-3.09 | $-5.38 | $-5.00 | $-2.43 |
| Acciones en Circulación (Diluidas) | $1.1M | $5.7M | $10.1M | $11.5M | $12.1M | $19.8M | $58.6M | $87.4M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$49.2M | 0 | -$753000 | 0 |
| Beneficio Operativo | -$60.1M | -$72.9M | -$59.3M | -$78.1M |
| EBITDA | -$56.9M | -$69.1M | -$53.1M | -$72.2M |
| Beneficio Neto | -$57.5M | -$69.9M | -$53.8M | -$73.1M |
| BPA | $-0.65 | $-0.76 | $-0.48 | $-0.65 |
| BPA Diluido | $-0.65 | $-0.76 | $-0.48 | $-0.65 |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $1.6M | $2.5M | $39.8M | $49.2M | $20.3M | $98.7M | $143.4M | $653.5M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | $39.5M | $74.0M | 0 |
| Cuentas por Cobrar | 0 | 0 | $850000 | $4.3M | $847000 | $289000 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $2.1M | $3.1M | $42.9M | $56.6M | $22.6M | $144.7M | $221.3M | $660.8M |
| Inmovilizado Material | $2.1M | $1.7M | $1.5M | $855000 | $965000 | $3.6M | $14.4M | $17.6M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $4.4M | $5.1M | $44.5M | $57.9M | $24.0M | $148.5M | $240.2M | $683.2M |
| Cuentas por Pagar | $473000 | $548000 | $1.2M | $3.1M | $2.4M | $3.3M | $14.2M | $3.3M |
| Deuda a Corto | $225000 | $212000 | $479000 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $1.6M | $1.7M | $3.0M | $9.7M | $7.3M | $21.8M | $54.3M | $45.0M |
| Deuda a Largo | $325000 | $113000 | $134000 | 0 | 0 | 0 | 0 | $3.9M |
| Pasivos Totales | $29.7M | $40.7M | $3.2M | $9.7M | $7.4M | $28.7M | $59.1M | $48.8M |
| Reservas | -$26.1M | -$36.6M | -$54.4M | -$79.1M | -$116.0M | -$222.8M | -$515.8M | -$728.2M |
| Patrimonio Neto | -$25.2M | -$35.6M | $41.3M | $48.2M | $16.7M | $119.9M | $181.2M | $634.3M |
| Deuda Total | $1.2M | $564000 | $613000 | $317000 | $291000 | $1.6M | $4.8M | $3.9M |
| Deuda Neta | -$426000 | -$2.0M | -$39.2M | -$48.9M | -$20.0M | -$136.5M | -$212.5M | -$649.6M |
| Capital Circulante | $550000 | $1.5M | $39.9M | $46.9M | $15.3M | $122.9M | $167.0M | $615.8M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $272.6M | $653.5M | $582.7M | $217.7M |
| Activos Totales | $299.4M | $683.2M | $619.8M | $565.4M |
| Pasivos Totales | $35.5M | $48.8M | $31.1M | $40.3M |
| Patrimonio Neto | $263.9M | $634.3M | $588.7M | $525.1M |
| Deuda Total | $4.0M | $3.9M | $3.7M | $4.6M |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$7.8M | -$10.4M | -$17.8M | -$24.7M | -$36.9M | -$106.8M | -$293.0M | -$212.4M |
| Amortizaciones | $521000 | $615000 | $755000 | $755000 | $631000 | $728000 | $2.1M | $3.0M |
| Compensación en Acciones | $11000 | $14000 | $621000 | $3.4M | $5.3M | $6.2M | $15.7M | $25.7M |
| Cambio en Capital Circulante | -$102000 | $212000 | -$1.2M | $2.8M | $2.2M | $12.0M | $14.9M | -$15.2M |
| Flujo de Caja Operativo | -$7.4M | -$9.6M | -$12.1M | -$18.2M | -$28.7M | -$7.6M | -$110.8M | -$190.9M |
| Inversiones (CapEx) | -$228000 | -$233000 | -$586000 | -$79000 | -$248000 | -$831000 | -$53.5M | -$9.7M |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | $9.3M | 0 | 0 |
| Recompra de Acciones | 0 | -$35000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$7.6M | -$9.8M | -$12.7M | -$18.3M | -$28.9M | -$8.4M | -$164.3M | -$200.6M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$40.5M | -$48.0M | -$58.6M | -$61.7M |
| Inversiones (CapEx) | -$1.1M | -$4.0M | -$3.0M | -$2.2M |
| Flujo de Caja Libre | -$41.6M | -$52.0M | -$61.6M | -$63.9M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $6.7M | $7.9M | $8.0M | $8.8M |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | | | | | -35.5% | -23.2% |
| Crecimiento Beneficio Neto (anual) | | -34.5% | -69.1% | -38.5% | -49.3% | -189.5% | -174.3% | +27.5% |
| Crecimiento BPA (anual) | | +74.4% | +8.2% | -26.6% | -44.4% | -74.1% | +7.1% | +51.4% |
| Cambio en Acciones (anual) | | +425.8% | +76.0% | +14.1% | +5.1% | +63.6% | +195.5% | +49.0% |
| Crecimiento FCF (anual) | | -28.8% | -29.4% | -43.9% | -58.1% | +71.0% | -1856.2% | -22.1% |
| Margen Bruto | | | | | | 100.0% | 100.0% | 57.4% |
| Margen Operativo | | | | | | -781.4% | -3382.4% | -3084.8% |
| Margen EBITDA | | | | | | -199.7% | -1674.1% | -3017.4% |
| Margen Neto | | | | | | -761.9% | -3240.4% | -3060.0% |
| Margen FCF | | | | | | -59.9% | -1817.3% | -2890.1% |
| Tasa Impositiva Efectiva | -0.5% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-6.99 | $-1.71 | $-1.26 | $-1.59 | $-2.39 | $-0.42 | $-2.80 | $-2.30 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $1.1M | $5.7M | $10.1M | $11.5M | $12.1M | $19.8M | $58.6M | $87.4M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -50.56% |
| Rentabilidad sobre capital invertido | -51.06% |
| Rentabilidad sobre activos | -44.98% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 15.08 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 21.61 |
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -1.87 | -7.31 | -5.73 | -6.06 | -0.72 | -1.99 | -2.12 | -8.84 |
| P/VC | -0.58 | -2.17 | 2.37 | 3.10 | 1.61 | 1.77 | 3.44 | 2.96 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.15 | 68.88 | 270.32 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 100.0% | 100.0% | 57.4% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -781.4% | -3382.4% | -3084.8% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -761.9% | -3240.4% | -3060.0% |